is semaglutide patented The upcoming expiry of the patent in India in mid-March 2026 expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Patent Expiry Day: Novo Nordisk
Description
They produce greater weight loss, require weekly injections, and have broader NHS availability
J Mol Cell Cardiol 2015;89:365375
For a night or two, possibly
Following recommended dose escalation schedules and consuming smaller, lower-fat meals may help minimise digestive discomfort
It is also used to treat obesity by improving glycemic control
